List of Tables:
Table 1. Snapshot of Europe Minimal Residual Disease Testing Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in Europe Minimal Residual Disease Testing Market 33
Table 5. Europe Minimal Residual Disease Testing Market by Offering, 2021-2031, $ mn 41
Table 6. Europe Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 45
Table 7. Europe Minimal Residual Disease Testing Market: Non-Hodgkins Lymphoma (NHL) by Type, 2021-2031, $ mn 48
Table 8. Europe Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 63
Table 9. Main Vendors and Products of Flow Cytometry Technology 65
Table 10. Main Vendors and Products of Polymerase Chain Reaction (PCR) Technology 66
Table 11. Main Vendors and Products of Next-Generation Sequencing (NGS) Technology 67
Table 12. Europe Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 69
Table 13. Europe Minimal Residual Disease Testing Market by Country, 2021-2031, $ mn 77
Table 14. Germany Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 79
Table 15. Germany Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 79
Table 16. Germany Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 79
Table 17. U.K. Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 81
Table 18. U.K. Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 81
Table 19. U.K. Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 81
Table 20. France Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 83
Table 21. France Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 83
Table 22. France Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 83
Table 23. Spain Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 85
Table 24. Spain Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 85
Table 25. Spain Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 85
Table 26. Italy Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 87
Table 27. Italy Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 87
Table 28. Italy Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 87
Table 29. Netherlands Minimal Residual Disease Testing Market by Application, 2021-2031, $ mn 89
Table 30. Netherlands Minimal Residual Disease Testing Market by Technology, 2021-2031, $ mn 89
Table 31. Netherlands Minimal Residual Disease Testing Market by End User, 2021-2031, $ mn 89
Table 32. Minimal Residual Disease Testing Market in Rest of Europe by Country, 2021-2031, $ mn 91
Table 33. Breakdown of World Market by Key Vendor, 2021, % 94
Table 34. Approved and Launched MRD Testing Products of Key Vendors 94
Table 35. Adaptive Biotechnologies Corporation: Company Snapshot 97
Table 36. Adaptive Biotechnologies Corporation: Business Segmentation 98
Table 37. Adaptive Biotechnologies Corporation: Product Portfolio 98
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Europe Minimal Residual Disease Testing Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of Europe Minimal Residual Disease Testing Market 24
Figure 7. World Number of Deaths from Cancers in 201 27
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 10. Primary Restraints and Impact Factors of Europe Minimal Residual Disease Testing Market 30
Figure 11. Investment Opportunity Analysis 34
Figure 12. Porters Fiver Forces Analysis of Europe Minimal Residual Disease Testing Market 37
Figure 13. Breakdown of Europe Minimal Residual Disease Testing Market by Offering, 2021-2031, % of Revenue 42
Figure 14. Europe Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 42
Figure 15. Europe Minimal Residual Disease Testing Market by Offering: Services, 2021-2031, $ mn 43
Figure 16. Europe Minimal Residual Disease Testing Market by Offering: Test Kits & Consumables, 2021-2031, $ mn 44
Figure 17. Breakdown of Europe Minimal Residual Disease Testing Market by Application, 2021-2031, % of Sales Revenue 46
Figure 18. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 46
Figure 19. Europe Minimal Residual Disease Testing Market by Application: Non-Hodgkins Lymphoma (NHL), 2021-2031, $ mn 47
Figure 20. Europe Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): DLBCL, 2021-2031, $ mn 49
Figure 21. Europe Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Marginal Zone Lymphoma, 2021-2031, $ mn 50
Figure 22. Europe Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Follicular Lymphoma, 2021-2031, $ mn 51
Figure 23. Europe Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Peripheral T-cell Lymphoma, 2021-2031, $ mn 52
Figure 24. Europe Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Mantle Cell Lymphoma, 2021-2031, $ mn 53
Figure 25. Europe Minimal Residual Disease Testing Market by Non-Hodgkins Lymphoma (NHL): Other NHLs, 2021-2031, $ mn 54
Figure 26. Europe Minimal Residual Disease Testing Market by Application: Multiple Myeloma (MM), 2021-2031, $ mn 55
Figure 27. Europe Minimal Residual Disease Testing Market by Application: Acute Lymphoblastic Leukemia (ALL), 2021-2031, $ mn 56
Figure 28. Europe Minimal Residual Disease Testing Market by Application: Chronic Lymphoblastic Leukemia (CLL), 2021-2031, $ mn 57
Figure 29. Europe Minimal Residual Disease Testing Market by Application: Acute Myeloid Leukemia (AML), 2021-2031, $ mn 58
Figure 30. Europe Minimal Residual Disease Testing Market by Application: Chronic Myeloid Leukemia (CML), 2021-2031, $ mn 59
Figure 31. Europe Minimal Residual Disease Testing Market by Application: Hodgkins Lymphoma (HL), 2021-2031, $ mn 60
Figure 32. Europe Minimal Residual Disease Testing Market by Application: Solid Tumor, 2021-2031, $ mn 61
Figure 33. Europe Minimal Residual Disease Testing Market by Application: Other Applications, 2021-2031, $ mn 62
Figure 34. Breakdown of Europe Minimal Residual Disease Testing Market by Technology, 2021-2031, % of Sales Revenue 64
Figure 35. Europe Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 64
Figure 36. Europe Minimal Residual Disease Testing Market by Technology: Flow Cytometry, 2021-2031, $ mn 65
Figure 37. Europe Minimal Residual Disease Testing Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 66
Figure 38. Europe Minimal Residual Disease Testing Market by Technology: Next-Generation Sequencing (NGS), 2021-2031, $ mn 67
Figure 39. Europe Minimal Residual Disease Testing Market by Technology: Other Technologies, 2021-2031, $ mn 68
Figure 40. Breakdown of Europe Minimal Residual Disease Testing Market by End User, 2021-2031, % of Revenue 70
Figure 41. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 70
Figure 42. Europe Minimal Residual Disease Testing Market by End User: Hospitals and Clinics, 2021-2031, $ mn 71
Figure 43. Europe Minimal Residual Disease Testing Market by End User: Research Institutions, 2021-2031, $ mn 72
Figure 44. Europe Minimal Residual Disease Testing Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 73
Figure 45. Europe Minimal Residual Disease Testing Market by End User: Other End Users, 2021-2031, $ mn 74
Figure 46. Breakdown of European Minimal Residual Disease Testing Market by Country, 2021 and 2031, % of Revenue 76
Figure 47. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 77
Figure 48. Minimal Residual Disease Testing Market in Germany, 2021-2031, $ mn 78
Figure 49. Minimal Residual Disease Testing Market in U.K., 2021-2031, $ mn 80
Figure 50. Minimal Residual Disease Testing Market in France, 2021-2031, $ mn 82
Figure 51. Minimal Residual Disease Testing Market in Spain, 2021-2031, $ mn 84
Figure 52. Minimal Residual Disease Testing Market in Italy, 2021-2031, $ mn 86
Figure 53. Minimal Residual Disease Testing Market in Netherlands, 2021-2031, $ mn 88
Figure 54. Minimal Residual Disease Testing Market in Rest of Europe, 2021-2031, $ mn 90
Figure 55. Growth Stage of Europe Minimal Residual Disease Testing Industry over the Forecast Period 92
